Mouse Anti-Human B-Cells (FMC7 Antigen) Monoclonal Antibody, FITC Conjugated from AbD Serotec
... boxes are ideal for use in refrigerators, freezer...arious storage racks. Four vibrant colors allow fo...n the bottom allow liquid nitrogen drainage or pro....7 mm cell) grid which holds 81 tubes. Box dimen...
Rabbit Anti-PARATHION Polyclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-Bacterial HISTIDASE Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products:...cher has found that sick female deer mice devote t...isa Schwanz, a researcher in the department of eco...e size of offspring for both infected and healthy ... with a parasite produced larger offspring than he...use most mammals tend to focus on their own surviv...
... Amyloid deposits in tissues and organs are linked...rkinsons, type II diabetes, and prion diseases suc...cal substances; they have potential as a nanomater...ecular assemblies exceed those of synthetic polyme...n the journal Angewandte Chemie, since the buildin...
...ission has awarded 4.5 million to a pan-European c...opes biological data resources into a sustainable,...ciences. The European Life-science Infrastructure ... by the European Molecular Biology Laboratorys Eur...lves 32 partners from 13 countries. The consortium...
Other Biology News:Mice mothers devote energies to offspring when life is threatened 2Protein fibrils as alternative plastics? 2Securing the future of Europe's biological data resources 2(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Dutch Biotech Company Pepscan Appoints New CEO 2